Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · March 09, 2021

IL-6 Receptor Antagonists in Severe COVID-19

The New England Journal of Medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

The New England Journal of Medicine
Interleukin-6 Receptor Antagonists in Critically Ill Patients With Covid-19
N. Engl. J. Med 2021 Feb 25;[EPub Ahead of Print], , AC Gordon, PR Mouncey, F Al-Beidh, KM Rowan, AD Nichol, YM Arabi, D Annane, A Beane, W van Bentum-Puijk, LR Berry, Z Bhimani, MJM Bonten, CA Bradbury, FM Brunkhorst, A Buzgau, AC Cheng, MA Detry, EJ Duffy, LJ Estcourt, M Fitzgerald, H Goossens, R Haniffa, AM Higgins, TE Hills, CM Horvat, F Lamontagne, PR Lawler, HL Leavis, KM Linstrum, E Litton, E Lorenzi, JC Marshall, FB Mayr, DF McAuley, A McGlothlin, SP McGuinness, BJ McVerry, SK Montgomery, SC Morpeth, S Murthy, K Orr, RL Parke, JC Parker, AE Patanwala, V Pettilä, E Rademaker, MS Santos, CT Saunders, CW Seymour, M Shankar-Hari, WI Sligl, AF Turgeon, AM Turner, FL van de Veerdonk, R Zarychanski, C Green, RJ Lewis, DC Angus, CJ McArthur, S Berry, SA Webb, LPG Derde

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading